商务合作
动脉网APP
可切换为仅中文
DUBLIN--(BUSINESS WIRE)--The 'Medical Device Software: Complying with the EU MDR, EU IVDR & FDA Regulations' conference has been added to ResearchAndMarkets.com's offering.
。
This intensive four-day course provides a comprehensive appraisal of the regulations and requirements that apply to medical device software worldwide.
这门为期四天的强化课程全面评估了适用于全球医疗器械软件的法规和要求。
The programme will be highly interactive, using real-life examples and state-of-the-art practices identified by Notified Bodies in Europe. There will be in-depth coverage on how to prepare compliant technical file documentation for medical device software products and a review of software specification, risk management, architectures, usability and resulting design documentation.
该计划将高度互动,使用现实生活中的例子和欧洲通知机构确定的最新实践。将深入介绍如何为医疗器械软件产品准备符合要求的技术文件文档,以及对软件规范、风险管理、体系结构、可用性和最终设计文档的审查。
Presentations will also offer practical tips on how to streamline the development process and provide an understanding of the regulatory requirements and how Notified Bodies review technical files..
演示还将提供有关如何简化开发过程的实用技巧,并提供对法规要求的理解,以及通知机构如何审查技术文件。。
There will be sessions on the practical implication of risk management and usability and an analysis of the differences between FDA guidance and MDR guidance on medical device software. Software recalls, the use of apps in medical devices, the implications of the new draft usability standard, and advice on how to validate your system design will also be addressed..
会议将讨论风险管理和可用性的实际意义,并分析FDA指南和MDR指南在医疗器械软件方面的差异。软件召回、应用程序在医疗设备中的使用、新的可用性标准草案的含义以及如何验证系统设计的建议也将得到解决。。
This course is part of our Regulatory Affairs Training course collection, which features updates on the latest regulations to registration procedures and strategies.
。
Why you should attend
你为什么要参加
Learn how to qualify and classify software in Europe and the rest of the world
了解如何对欧洲和世界其他地区的软件进行鉴定和分类
Get in-depth understanding of the interpretations of MDR Classification Rules 10, 11, 12, 13, 15 and 22
深入了解MDR分类规则10、11、12、13、15和22的解释
Understand the implications of the MDR and US Code of Federal Regulations for software
了解MDR和美国联邦法规对软件的影响
Gain regulatory guidance on mobile apps, software as a service, cloud computing, artificial intelligence and continuous learning software
获得有关移动应用程序、软件即服务、云计算、人工智能和持续学习软件的监管指导
Learn how to write 510(k) and technical files
了解如何编写510(k)和技术文件
Get a practical understanding of quality management, design control and how it applies to agile software development
实际了解质量管理、设计控制以及它如何应用于敏捷软件开发
Hear the best practices on cyber security, risk management, usability and validation
听取有关网络安全、风险管理、可用性和验证的最佳实践
Learn the principles of clinical evaluations for software as a medical device
学习软件作为医疗设备的临床评估原则
Gain an insight into state-of-the-art standards applicable to software
深入了解适用于软件的最新标准
Certifications
所获证书
CPD: 24 hours for your records
CPD:24小时记录
Certificate of completion
竣工证书
Who Should Attend:
参加人员:
Senior management and project leaders
高级管理人员和项目负责人
Software product managers, researchers, developers and clinical experts
软件产品经理、研究人员、开发人员和临床专家
Software development process managers
软件开发过程经理
IT managers and integrators
IT经理和集成商
Internal and external auditors and/or consultants
内部和外部审计师和/或顾问
Regulatory affairs professionals
监管事务专业人员
Quality system and quality assurance personnel
质量体系和质量保证人员
Technical and medical writers
技术和医学作家
GUI designers
GUI设计器
Agenda:
议程:
Day 1
第1天
Introduction to the regulations
条例简介
Software qualification - is it a medical device or not?
软件鉴定-它是否是医疗设备?
Medical device definitions
医疗器械定义
In-vitro diagnostic software
体外诊断软件
Multi-functionality software
多功能软件
Cloud computing and software as a service
云计算和软件即服务
Intended purpose
预期用途
Excluded functionality
排除的功能
Borderline with lifestyle and fitness software
生活方式和健身软件的边缘
Borderline with pharmaceuticals, combination products
与药品、组合产品接壤
Companion diagnostics, medication management and adherence apps
配套诊断、药物管理和依从性应用程序
Population health and educational software
人口健康与教育软件
Resource and workflow management vs clinical decision support software
资源和工作流管理与临床决策支持软件
Clinical decision software
临床决策软件
Considerations for placement on the market
关于上市的考虑
International comparisons-qualification differences (US, Canada, Brazil)
国际比较资格差异(美国、加拿大、巴西)
Pitfalls with the interpretation of the IMDRF SaMD risk framework
IMDRF SaMD风险框架解释中的陷阱
Pros and cons of the modular approach software platforms
模块化方法软件平台的优缺点
Software accessories, systems components
软件附件、系统组件
Legal status of wearables
可穿戴设备的法律地位
Case studies - qualification
案例研究-资格
Day 2
第2天
Software classification
Implementing rules
实施规则
Software that drives or influences the use of a (hardware) medical device
驱动或影响(硬件)医疗设备使用的软件
Classification rules, including classification rule 11
分类规则,包括分类规则11
IMDRF SaMD risk type determination
IMDRF SaMD风险类型确定
Case studies - classification
案例研究-分类
MDR in a nutshell with software considerations
简而言之,MDR需要考虑软件因素
Go to market process
上市流程
Engaging with a Notified Body
与公告机构接洽
Controlling software suppliers and subcontractors
控制软件供应商和分包商
UDI number
EUDAMED
尤达梅德
Declaration of Conformity
符合性声明
Person responsible for regulatory compliance
法规遵从性负责人
Software traceability
软件可追溯性
Distributors, importers, authorised representatives and their liability
分销商、进口商、授权代表及其责任
App stores and digital distribution platforms
应用商店和数字分发平台
Software recalls
软件召回
Unannounced Notified Body audits
未经通知的审计机构
Service updates, upgrades and other changes
服务更新、升级和其他更改
Case study: a great idea!
案例研究:一个好主意!
Safety and performance requirements for software
软件的安全和性能要求
Harmonised standards
调和标准
Common specifications
通用规范
GSPR checklist
GSPR检查表
Software labelling
软件标签
IT environment and mobile platforms
IT环境和移动平台
Repeatability and reliability of machine learning software
机器学习软件的可重复性和可靠性
Software labeling
软件标签
Instructions for use
使用说明
Practical construction of a technical file
技术档案的实际建设
Content
内容
Example
示例
Placing medical device software on the US market
将医疗器械软件投放美国市场
US Code of Federal Regulations and its' implications for software
美国联邦法规及其对软件的影响
510(k) process
510(k)工艺
FDA Guidances specific for software
FDA软件专用指南
FDA expectations for machine learning software
FDA对机器学习软件的期望
Practical construction of a 510(k)
510(k)的实际构造
International go-to-market considerations
Challenges faced for app developers to have their app taken up in care pathways
应用程序开发人员将其应用程序纳入护理路径所面临的挑战
Quality and reliability of health and wellness apps
健康和健康应用程序的质量和可靠性
Evolving policy and reimbursement landscapes for digital health technologies
数字健康技术政策和报销格局的演变
Quality and reliability of health and wellness apps
健康和健康应用程序的质量和可靠性
Day 3
第3天
Controlled design of health software
健康软件的受控设计
Software development models
软件开发模型
Symptoms and root causes of poor design control
设计控制不佳的症状和根本原因
Waterfall vs Agile, iterative and spiral
瀑布vs敏捷、迭代和螺旋
Principles of good design control
良好设计控制原则
Stage-gated model
阶段门控模型
Design activities
设计活动
Project management
项目管理
Development planning
发展规划
Change management
变更管理
Requirements management
需求管理
Architecture & design
建筑与设计
Development
发展
Configuration management
配置管理
Verification & validation
验证和确认
Defect management
缺陷管理
Design reviews
设计审查
Software development standards
软件开发标准
IEC 62304 software life-cycle management
IEC 62304软件生命周期管理
IEC 82304-1 general requirements for product safety
IEC 82304-1产品安全的一般要求
Outsourcing
外包
Management of software suppliers
软件供应商管理
Critical suppliers
关键供应商
Software platforms and plugins
软件平台和插件
Use of open source software
使用开源软件
Legacy software
遗留软件
Software usability
软件可用性
Managing the human element of risk
管理风险的人为因素
Designing for happiness
为幸福而设计
Terminology, roles and responsibilities
术语、角色和责任
Use Experience Design (UXD)
使用体验设计(UXD)
Process and techniques
工艺和技术
Formative evaluation
形成性评价
User observations
用户观察
Walkthroughs
演练
Heuristic review
启发式审查
Key-stroke level model
关键行程级别模型
Summative evaluation
总结性评价
Product reaction cards / word association
产品反应卡/单词关联
Single Ease Question (SEQ)
单一缓解问题(SEQ)
System Usability Score (SUS)
系统可用性评分(SUS)
Interface with risk management
与风险管理的接口
Regulatory requirements and standards
监管要求和标准
EU MDR/IVDR requirements
欧盟MDR/IVDR要求
USA FDA requirements
美国FDA要求
IEC 62366-1, etc.
IEC 62366-1等。
Usability guides
Safety risk management - ISO 14971
Process, terminology, roles
流程、术语、角色
Risk Identification Methodologies
风险识别方法
Checklists
检查表
Grey box
灰色方框
Hazard and Operability Analysis (HAZOP)
危害和可操作性分析(HAZOP)
Failure Modes and Effects Anaylsis (FMEA)
故障模式和影响分析(FMEA)
Fault Tree Analysis (FTE)
故障树分析(FTE)
Risk Control
风险控制
Inherently safe design
本质安全设计
Preventive measures
预防措施
Corrective measures
纠正措施
Mitigations
缓解措施
Safety notices
安全注意事项
Disclosures of residual risk
剩余风险披露
Risk control strategies
风险控制策略
Risk assessment and evaluation
风险评估和评估
IMDRF terminology
IMDRF术语
Determining severity and probability of harm
确定危害的严重程度和可能性
Determining if a risk is acceptable
Benefit-risk assessment
Deliverables
Other risk management aspects
其他风险管理方面
Risk management throughout the product life-cycle
整个产品生命周期的风险管理
Risk management of ESCs, SOUPs, COTS and platforms
ESC、汤、COTS和平台的风险管理
Risk perception and communication
风险感知和沟通
Day 4
第4天
Clinical evaluations
Definitions, purpose, deliverables
定义、目的、可交付成果
Process and key characteristics
Selecting data sources
选择数据源
Defining a scope and a sufficient level of clinical evidence for medical device software
定义医疗器械软件的范围和足够水平的临床证据
Role of validation and usability
验证和可用性的作用
Considerations for artificial intelligence and continuous learning software
关于人工智能和持续学习软件的思考
Development of a literature review protocol
制定文献综述方案
Selecting databases and conducting searches
选择数据库并进行搜索
Defining search strategy
定义搜索策略
Case studies - clinical evaluation of medical device software
案例研究-医疗器械软件的临床评估
Clinical investigations and performance studies
临床调查和性能研究
General principles of clinical investigations
临床研究的一般原则
When is a clinical investigation needed for medical device software
医疗器械软件何时需要临床调查
Selecting appropriate study design
选择合适的研究设计
Application of standards
标准的应用
Clinical performance studies
临床表现研究
Generating evidence of effectiveness
产生有效性证据
Challenges of health trials
Reporting
Regulatory and ethical considerations
监管和道德考虑
Post-Market Surveillance and Post-Market Clinical Follow up
上市后监测和上市后临床随访
Post-market regulatory requirements
上市后监管要求
Components of an effective PMS
有效PMS的组成部分
Process interface with CAPA, NC, vigilance, service, periodic safety updates, trend reporting
与CAPA、NC、警戒、服务、定期安全更新、趋势报告的流程接口
Implementation of Post Market Clinical Follow-up for medical device software
医疗器械软件上市后临床随访的实施
Real-World Evidence
真实世界的证据
Successfully bringing together Risk Management, Clinical Evaluation and Post Market Surveillance to streamline ways of working
成功地将风险管理、临床评估和上市后监测结合在一起,以简化工作方式
Speakers:
发言人:
Koen Cobbaert
柯恩·科巴特
Agfa HealthCare
爱克发医疗保健
QARA Manager
QARA经理
Koen Cobbaert is chair of COCIR's software task force. He is one of the authors of the first edition of MEDDEV 2.1/6 on standalone software and the FAQ on 62304:2006.
科恩·科伯特是COCIR软件工作组的主席。他是独立软件MEDDEV 2.1/6第一版和62304:2006常见问题解答的作者之一。
In his day to day job he works for Agfa Healthcare as regulatory affairs and quality assurance professional in the development of software applications for use in the fields of general radiology, nuclear medicine, cardiology and orthopaedics.
在日常工作中,他在Agfa Healthcare担任监管事务和质量保证专业人员,负责开发用于普通放射学、核医学、心脏病学和骨科领域的软件应用程序。
He has a masters in electrical engineering and risk management and manages Agfa's product safety risk management process.
他拥有电气工程和风险管理硕士学位,并管理Agfa的产品安全风险管理流程。
For more information about this conference visit https://www.researchandmarkets.com/r/bxauic
有关本次会议的更多信息,请访问https://www.researchandmarkets.com/r/bxauic
About ResearchAndMarkets.com
关于ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
ResearchAndMarkets.com是全球领先的国际市场研究报告和市场数据来源。我们为您提供有关国际和地区市场、关键行业、顶尖公司、新产品和最新趋势的最新数据。